| Date Filed | Type | Description |
| 04/26/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 01/27/2023 |
SC 13G
| MAGELLAN HEALTH INC reports a 8.4% stake in Evolent Health, Inc. |
| 02/14/2022 |
SC 13G
| UBS OCONNOR LLC reports a 5.2% stake in Magellan Health, Inc. |
| 02/10/2022 |
SC 13G/A
| VANGUARD GROUP INC reports a 9.6% stake in Magellan Health Inc. |
| 02/08/2022 |
SC 13G/A
| DIMENSIONAL FUND ADVISORS LP reports a 4.8% stake in Magellan Health Inc |
| 02/02/2022 |
SC 13G/A
| VICTORY CAPITAL MANAGEMENT INC reports a 0% stake in Magellan Health Inc. |
| 01/26/2022 |
SC 13G/A
| BlackRock Inc. reports a 14.7% stake in MAGELLAN HEALTH INC |
| 01/25/2022 |
SC 13G
| BlackRock Inc. reports a 14.7% stake in MAGELLAN HEALTH INC |
| 01/14/2022 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
| 01/06/2022 |
SC 13D/A
| Starboard Value LP reports a 0% stake in Magellan Health, Inc. |
| 01/04/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/04/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/04/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/04/2022 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
| 01/04/2022 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
| 12/30/2021 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 11/05/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 11/05/2021 |
8-K
| Quarterly results |
| 08/05/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 08/05/2021 |
8-K
| Quarterly results |
| 07/06/2021 |
SC 13G
| GLAZER CAPITAL, LLC reports a 5% stake in Magellan Health, Inc |
| 04/30/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
| 04/30/2021 |
8-K
| Quarterly results |
| 04/29/2021 |
10-K/A
| Annual Report for the period ended December 31, 2020 [amend] |
| 04/27/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/31/2021 |
8-K
| Quarterly results |
| 03/19/2021 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 03/19/2021 |
8-K
| Quarterly results |
| 03/13/2021 |
GN
| STOCK ALERT: Halper Sadeh LLP Investigates MGLN, CATM, EGOV, ALXN; Shareholders Are Encouraged to Contact the Firm |
| 02/26/2021 |
10-K
| Annual Report for the period ended December 31, 2020 |
| 02/26/2021 |
8-K
| Quarterly results |
| 02/25/2021 |
GN
| INVESTIGATION ALERT: Halper Sadeh LLP Investigates TPCO, MGLN, WDR, TCF; Shareholders Are Encouraged to Contact the Firm |
| 02/19/2021 |
DEFM14A
| Form DEFM14A - Definitive proxy statement relating to merger or acquisition: |
|